METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS USING N6 - CYCLOPENTYLADENOSINE (CPA), CPA DERIVATIVES OR PRODRUGS THEREOF

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11760319.1

公开号：

EP2569325A1

申请日:

2011.03.25

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Provided herein is a method of reducing intraocular pressure (IOP) in humans using N6-cyclopentyladenosine (CPA), CPA derivatives or prodrugs or enhanced cornea permeability formulations of CPA. In one embodiment, the invention is directed to CPA derivatives or prodrugs that are permeable to the cornea. In another embodiment, the invention is directed to uses of certain compounds in human subjects for reducing and/or controlling elevated or abnormally fluctuating IOPs in the treatment of glaucoma or ocular hypertension (OHT).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/